These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22415357)

  • 21. Estradiol and testosterone concentrations in follicular fluid as criteria to discriminate between mature and immature oocytes.
    Costa LO; Mendes MC; Ferriani RA; Moura MD; Reis RM; Silva de Sá MF
    Braz J Med Biol Res; 2004 Nov; 37(11):1747-55. PubMed ID: 15517092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular fluid from infertile women with mild endometriosis may compromise the meiotic spindles of bovine metaphase II oocytes.
    Da Broi MG; Malvezzi H; Paz CC; Ferriani RA; Navarro PA
    Hum Reprod; 2014 Feb; 29(2):315-23. PubMed ID: 24166595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female reproductive functions of the neuropeptide PACAP.
    Koppan M; Nagy Z; Bosnyak I; Reglodi D
    Front Endocrinol (Lausanne); 2022; 13():982551. PubMed ID: 36204113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and functional activity of PACAP and its receptors on cumulus cells: effects on oocyte maturation.
    Barberi M; Di Paolo V; Latini S; Guglielmo MC; Cecconi S; Canipari R
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):79-88. PubMed ID: 23684890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.
    Liu N; Ma Y; Li R; Jin H; Li M; Huang X; Feng HL; Qiao J
    Endocrine; 2012 Dec; 42(3):708-16. PubMed ID: 22678853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of homocysteine in follicular fluid and embryo quality and oocyte maturity in infertile women: a prospective cohort.
    Razi Y; Eftekhar M; Fesahat F; Dehghani Firouzabadi R; Razi N; Sabour M; Razi MH
    J Obstet Gynaecol; 2021 May; 41(4):588-593. PubMed ID: 32749170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.
    Qiao J; Lu G; Zhang HW; Chen H; Ma C; Olofsson JI; Witjes H; Heijnen E; Mannaerts B
    Gynecol Endocrinol; 2012 Oct; 28(10):800-4. PubMed ID: 22429192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular fluid anti-Müllerian hormone: a predictive marker of fertilization capacity of MII oocytes.
    Tramišak Milaković T; Panić Horvat L; Čavlović K; Smiljan Severinski N; Vlašić H; Vlastelić I; Ljiljak D; Radojčić Badovinac A
    Arch Gynecol Obstet; 2015 Mar; 291(3):681-7. PubMed ID: 25205183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C; Park-Sarge OK
    Biochem Biophys Res Commun; 2000 Oct; 277(1):270-9. PubMed ID: 11027674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles.
    Vuong TNL; Ho MT; Ha TQ; Jensen MB; Andersen CY; Humaidan P
    J Assist Reprod Genet; 2017 Apr; 34(4):471-478. PubMed ID: 28197932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study.
    Haas J; Ophir L; Barzilay E; Machtinger R; Yung Y; Orvieto R; Hourvitz A
    Fertil Steril; 2016 Sep; 106(3):653-659.e1. PubMed ID: 27341989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superovulation before IVF by recombinant versus urinary human FSH (combined with a long GnRH analog protocol): a comparative study.
    Fisch B; Avrech OM; Pinkas H; Neri A; Rufas O; Ovadia J; Loumaye E
    J Assist Reprod Genet; 1995 Jan; 12(1):26-31. PubMed ID: 7580006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells.
    Gräs S; Hannibal J; Georg B; Fahrenkrug J
    Endocrinology; 1996 Nov; 137(11):4779-85. PubMed ID: 8895347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study.
    Lainas GT; Lainas TG; Sfontouris IA; Venetis CA; Bosdou JK; Chatzimeletiou A; Grimbizis GF; Tarlatzis BC; Kolibianakis EM
    Reprod Biomed Online; 2020 Jan; 40(1):168-175. PubMed ID: 31839394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M; Hadziosmanovic N; Berglund L; Holte J
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.